Evaluation With Scans and Pharyngometry of the Possible Changes in Upper Airway Geometry Induced by Using Different Mouthpieces.
Assessment of the Effect of the Shape of an Inhaler's Mouthpiece on Upper Airway Geometry, Using Functional Respiratory Imaging and Pharyngometry.
1 other identifier
interventional
12
1 country
1
Brief Summary
In this study the possible changes in upper airway geometry induced by variations in the characteristics of the mouthpieces of inhalers will be evaluated with functional respiratory imaging (FRI) and Pharyngometry. The study population consists of 12 healthy male subjects. Different mouthpiece designs will be evaluated for each subject by using magnetic resonance imaging (MRI) scans. The results will help to identify the influence of the height, width, protrusion and resistance of the mouthpiece on upper airway geometry. Pharyngometry profiles of all subjects, whilst inhaling through different mouthpiece variants, in supine and upright position, will be completed. A computed tomography (CT) scan and a cone beam computed tomography (CBCT) scan of the upper airway will be taken to respectively compare the time dependence on 3D imaging with MRI and to provide a 3D image in an upright position. Dental impressions will be optically scanned to obtain a more accurate representation of the oral cavity, mainly in MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2012
CompletedFirst Posted
Study publicly available on registry
May 7, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedOctober 4, 2017
November 1, 2012
1 month
May 4, 2012
October 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in upper airway geometry by using MRI.
The primary objective of this study is to evaluate with MRI-FRI the possible changes in upper airway geometry induced by using different mouthpieces.
Within 20 days after day 1
Secondary Outcomes (1)
Changes in upper airway geometry by using pharyngometry in supine versus upright position.
Within 20 days after day 1
Other Outcomes (2)
Evaluate time dependence on image upper airway by using CT scan
At day 1
3D image of upper airway in upright position by using CBCT scan
At day 1
Interventions
11 MRI scans per subject will be taken, one for each mouthpiece design of an inhaler.
Pharyngometry will be carried out in supine and upright position. 11 different mouthpieces will be evaluated in both positions.
One low dose CT scan of the upper airway will be taken. The scan will be taken at normal inhalation through a mouthpiece with moderate resistance.
One CBCT scan of the upper airway will be taken. The scan will be taken at normal respiration through a mouthpiece with moderate resistance.
Dental impressions will be taken. These will be optically scanned before registration in the 3D imaging modalities.
Eligibility Criteria
You may qualify if:
- Male subject ≥ 18 years old
- Written informed consent obtained
- BMI ≥ 20 kg/m2 and \< 25 kg/m2
- Height ≥ 175 cm and ≤ 185 cm
- Subject must be able to understand and complete the protocol requirements, instructions and protocol-stated restrictions.
You may not qualify if:
- Subject with claustrophobia
- Subject with a history of surgery of the upper airway
- Subject with an enlarged thyroid gland
- Subject with intra-oral piercings
- Subject with dental bracket
- Subject with a pacemaker or another implant that is likely to interfere with the MRI procedure
- Subject that is unlikely to comply with the protocol or unable to understand the nature, scope and possible consequences of the study
- Subject who received any investigational new drug within the last 4 weeks prior to visit 1.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FLUIDDA nvlead
Study Sites (1)
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wilfried De Backer, MD, PhD
University Hospital, Antwerp
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2012
First Posted
May 7, 2012
Study Start
September 1, 2012
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
October 4, 2017
Record last verified: 2012-11